Labcorp Holdings (LH) EBIT Margin (2009 - 2026)

Labcorp Holdings has disclosed EBIT Margin across 18 years of filings, most recently posting 10.76% for Q1 2026.

• EBIT Margin for Q1 2026 came in at 10.76%, up 102.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 10.18% (up 189.0% YoY), and the FY2025 annual result was 9.92%, up 157.0% from the prior year.
• EBIT Margin came in at 10.76% for Q1 2026 at Labcorp Holdings, up from 7.61% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 17.64% in Q1 2022 to a low of 4.05% in Q4 2023.
• The 5-year median for EBIT Margin is 9.75% (2025), against an average of 9.07%.
• Across the five-year window, EBIT Margin slumped 4754 bps in 2022 and jumped 1055 bps in 2024, its largest moves.
• Labcorp Holdings' EBIT Margin stood at 0.97% in 2022, then tumbled by 516 bps to 4.05% in 2023, then soared by 261 bps to 6.5% in 2024, then climbed by 17 bps to 7.61% in 2025, then surged by 41 bps to 10.76% in 2026.
• The last three EBIT Margin figures came in at 10.76% (Q1 2026), 7.61% (Q4 2025), and 11.13% (Q3 2025), per Business Quant data.